HK67995A - Inhibition of in vitro infectivity and cytopathic effect of HTLV-III/LAV by 2'3'-dideoxycytidine - Google Patents

Inhibition of in vitro infectivity and cytopathic effect of HTLV-III/LAV by 2'3'-dideoxycytidine Download PDF

Info

Publication number
HK67995A
HK67995A HK67995A HK67995A HK67995A HK 67995 A HK67995 A HK 67995A HK 67995 A HK67995 A HK 67995A HK 67995 A HK67995 A HK 67995A HK 67995 A HK67995 A HK 67995A
Authority
HK
Hong Kong
Prior art keywords
htlv
iii
cells
lav
virus
Prior art date
Application number
HK67995A
Other languages
German (de)
English (en)
French (fr)
Inventor
Mitsuya Hiroaki
Broder Samuel
Original Assignee
The United States Of America As Represented By The Secretary United States Department Of Commerce
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The United States Of America As Represented By The Secretary United States Department Of Commerce filed Critical The United States Of America As Represented By The Secretary United States Department Of Commerce
Publication of HK67995A publication Critical patent/HK67995A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HK67995A 1985-08-26 1995-05-04 Inhibition of in vitro infectivity and cytopathic effect of HTLV-III/LAV by 2'3'-dideoxycytidine HK67995A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76901785A 1985-08-26 1985-08-26

Publications (1)

Publication Number Publication Date
HK67995A true HK67995A (en) 1995-05-12

Family

ID=25084170

Family Applications (1)

Application Number Title Priority Date Filing Date
HK67995A HK67995A (en) 1985-08-26 1995-05-04 Inhibition of in vitro infectivity and cytopathic effect of HTLV-III/LAV by 2'3'-dideoxycytidine

Country Status (12)

Country Link
EP (1) EP0216511B1 (cs)
JP (1) JPS62501777A (cs)
AT (1) ATE96326T1 (cs)
AU (1) AU570855B2 (cs)
CA (1) CA1277915C (cs)
DE (1) DE3689221T2 (cs)
HK (1) HK67995A (cs)
IE (1) IE63001B1 (cs)
IL (1) IL79699A (cs)
NL (1) NL940019I2 (cs)
NZ (1) NZ217184A (cs)
WO (1) WO1987001283A1 (cs)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR960001372B1 (ko) * 1986-09-24 1996-01-26 예일 유니버시티 레트로비루스로 감염된 환자의 치료에 사용되는 2',3'-디디옥시사이티딘-2'-엔(2',3'-디디옥시-2',3'-디디하이드로사이티딘)의 항생물질
IL86007A0 (en) * 1987-04-09 1988-09-30 Wellcome Found 6-substituted purine nucleosides,their preparation and pharmaceutical compositions containing them
GB8712691D0 (en) * 1987-05-29 1987-07-01 Wellcome Found Therapeutic nucleosides
IL86009A (en) * 1987-04-10 1991-09-16 Us Health Liposome-encapsulated phosphorylated nucleosides for treatment of retroviral diseases
EP0294113A1 (en) * 1987-05-29 1988-12-07 The Wellcome Foundation Limited Therapeutic nucleosides
US5028595A (en) * 1987-09-18 1991-07-02 Hoffmann-La Roche Inc. Method for preventing AIDS in a subject or treating a subject infected with the AIDS virus
JP2648329B2 (ja) * 1987-09-18 1997-08-27 エフ・ホフマン−ラ ロシュ アーゲー エイズの予防または治療用医薬組成物
AU2526188A (en) * 1987-09-22 1989-04-18 Regents Of The University Of California, The Liposomal nucleoside analogues for treating aids
JPH04501854A (ja) * 1989-05-15 1992-04-02 アメリカ合衆国 肝炎の治療方法
US5071983A (en) * 1989-10-06 1991-12-10 Burroughs Wellcome Co. Therapeutic nucleosides
US5192749A (en) * 1990-05-21 1993-03-09 Syntex (U.S.A.) Inc. 4'-substituted nucleosides
CA2270600A1 (en) 1999-05-03 2000-11-03 Infectio Recherche Inc. Method and formulations for the treatment of diseases, particularly those caused by human immunodeficiency virus and leishmania

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI87783C (fi) * 1985-05-15 1993-02-25 Wellcome Found Foerfarande foer framstaellning av terapeutiskt anvaendbara 2',3'-dideoxinukleosider

Also Published As

Publication number Publication date
AU6284386A (en) 1987-03-24
EP0216511A3 (en) 1989-08-02
EP0216511B1 (en) 1993-10-27
IE862264L (en) 1987-02-26
NZ217184A (en) 1990-03-27
IL79699A0 (en) 1986-11-30
DE3689221T2 (de) 1994-02-24
ATE96326T1 (de) 1993-11-15
WO1987001283A1 (en) 1987-03-12
JPH0215524B2 (cs) 1990-04-12
IL79699A (en) 1992-07-15
JPS62501777A (ja) 1987-07-16
NL940019I2 (nl) 1997-07-01
IE63001B1 (en) 1995-03-08
NL940019I1 (nl) 1994-12-01
AU570855B2 (en) 1988-03-24
DE3689221D1 (de) 1993-12-02
EP0216511A2 (en) 1987-04-01
CA1277915C (en) 1990-12-18

Similar Documents

Publication Publication Date Title
EP0216510B1 (en) Inhibition of in vitro infectivity and cytopathic effect of HTLV-III/LAV by 2'3'-dideoxyinosine, 2'3'-dideoxyguanosine, or 2'3'-dideoxyadenosine
US4880782A (en) Method of treating viral infections in humans and compositions therefor
Balzarini et al. The anti-HTLV-III (anti-HIV) and cytotoxic activity of 2', 3'-didehydro-2', 3'-dideoxyribonucleosides: a comparison with their parental 2', 3'-dideoxyribonucleosides.
Mitsuya et al. Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2', 3'-dideoxynucleosides.
Hayashi et al. Adenallene and cytallene: acyclic-nucleoside analogues that inhibit replication and cytopathic effect of human immunodeficiency virus in vitro.
Sarin et al. Inhibition of replication of the etiologic agent of acquired immune deficiency syndrome (human T-lymphotropic retrovirus/lymphadenopathy-associated virus) by avarol and avarone
US4788181A (en) 5-substituted-2',3'-dideoxycytidine compounds with anti-HTLV-III activity
AU598575B2 (en) Retrovirus treatments
IE860677L (en) Antiviral formulation
EP0216511B1 (en) Inhibition of in vitro infectivity and cytopathic effect of HTLV-III/LAV by 2'3'-dideoxycytidine
Shirasaka et al. Comparative analysis of anti-human immunodeficiency virus type 1 activities of dideoxynucleoside analogs in resting and activated peripheral blood mononuclear cells
US5616566A (en) Method of inhibiting HIV replication with 2',3'-dideoxyadenosine
EP0355825A2 (en) Viral treatment system
AU609099B2 (en) Methods of treating acquired immune deficiency syndrome (AIDS) caused by human immunodeficiency virus (HIV)
EP0493378A1 (en) Use of 2',3'-dideoxyguanosine for the treatment of AIDS
DE3724951A1 (de) Arzneimittel, enthaltend modifizierte desoxyribonukleinsaeure und dessen verwendung
IE19940570A1 (en) Use of 2',3'-dideoxyguanosine for the treatment of AIDS
IE83887B1 (en) Use of 2',3'-dideoxyguanosine for the treatment of AIDS
CA2050473A1 (en) Inhibition of hiv using synergistic combinations of nucleoside derivatives
EP0332626A1 (en) Compositions for treating viral infections in humans
Sarin et al. Lymphadenopathy-Associated Virus) by

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20060820